SOURCE: BioCentury This Week TV

BioCentury This Week TV

October 22, 2010 13:15 ET

Head of U.S. Patent and Trademark Office David Kappos Discusses Plan to Reward Humanitarian Inventions This Sunday on "BioCentury This Week" TV

Beyond Orphan Drugs: New Incentives for Humanitarian R&D

WASHINGTON, DC--(Marketwire - October 22, 2010) -  In a special interview airing this Sunday on "BioCentury This Week," Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office David Kappos lays out his plan to reward humanitarian inventions with vouchers to speed up intellectual property reviews.

The interview airs Sunday, October 24, on "BioCentury This Week," 8:30-9:00 A.M. EDT, on WUSA Channel 9 in Washington, D.C., and on Fox affiliate WFXT Channel 25 in Boston, with streaming video broadcast starting at 9:00 A.M. on

The program also features interviews with Dr. Melinda Moree, CEO of BIO Ventures for Global Health, who reviews the progress of Priority Review Vouchers for companies to develop treatments for neglected tropical diseases, and with Dr. Carolyn Asbury, Chair of the Board of Directors of the National Organization for Rare Disorders, and Dr. Nancy Sung, Senior Program Officer of the Burroughs Wellcome Fund, who explain the Institute of Medicine's recommendations for accelerating R&D for rare diseases.

"The humanitarian IP proposal is intended to incent innovation in areas that will help people be more healthy, that will get access to medicines they need, to sanitation they need, to clean water, and that will help people in impoverished parts of the world," Kappos told BioCentury Washington Editor Steve Usdin.

Under the proposed PTO incentive program, patent holders who disseminate their technologies for humanitarian purposes would qualify for vouchers for a fast-track re-examination to validate any patent. The vouchers could be transferred or sold to other patent holders. According to Kappos, the concept started with discussions with the biotech industry and is intended to align public health goals with the life science industry's needs for IP protection.

BioCentury This Week is a partnership of BioCentury Publications and W*USA, the Gannett Broadcasting flagship station and CBS affiliate serving the Washington, D.C. market. The program is part of the "Sunday Power Block" lineup, which includes Platt's Energy Week, CBS Sunday Morning; Face the Nation; This Week in Defense News; and The McLaughlin Group.

The Charter Sponsors of BioCentury This Week include Biogen Idec Inc., a global leader in the discovery, development, manufacturing and marketing of innovative therapies; the Biotechnology Industry Organization (BIO), representing more than 1,200 biotechnology companies, academic institutions and related organizations in the U.S. and 30 countries; and Rodman & Renshaw, a full-service investment bank.

About BioCentury®
Now in its 18th year, BioCentury Publications, Inc. is internationally recognized as the leading provider of biopharma business news, analysis and opinion covering corporate, emerging technology, partnering, clinical, regulation and public policy developments. BioCentury's journals include the flagship BioCentury, the Bernstein Report on BioBusiness; its SciBX: Science-Business eXchange translational science joint publishing venture with Nature Publishing Group; and its BioCentury Extra online daily newspaper. These timely publications are backed by BCIQ: BioCentury Online Intelligence, an online business intelligence resource. The company is widely acknowledged in the life science corporate and investment communities for pioneering the creation of three annual conferences that provide turf-neutral venues for biopharma investors, pharmaceutical licensing professionals and corporate executives to conduct business. BioCentury is headquartered in Redwood City, California, with offices in Washington, D.C.; Chicago; Chadds Ford, Pa.; and London.

About W*USA
W*USA is owned by the Gannett Company Inc. (NYSE: GCI). Gannett is an international news and information company operating on multiple platforms including the Internet, mobile, newspapers, magazines and TV stations. Gannett is an Internet leader with hundreds of newspaper and TV Web sites;, the nation's top employment site;; and more than 80 local sites. Gannett publishes 84 daily U.S. newspapers, including USA TODAY, the nation's largest-selling daily newspaper, and more than 700 magazines and other non-dailies including USA WEEKEND. Gannett also operates 23 television stations in 19 U.S. markets. Gannett subsidiary Newsquest is the United Kingdom's second largest regional newspaper company with 17 daily paid-for titles, more than 200 weekly newspapers, magazines and trade publications, and a network of Web sites.

Contact Information

  • Contact:
    Rosy Rogers
    Director of Marketing
    BioCentury Publications
    BioCentury This Week TV
    +1-650-595-5333 x 206
    Email Contact